Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9571 |
High Similarity |
NPD7074 |
Phase 3 |
0.9451 |
High Similarity |
NPD7472 |
Approved |
0.939 |
High Similarity |
NPD7054 |
Approved |
0.9281 |
High Similarity |
NPD7808 |
Phase 3 |
0.9277 |
High Similarity |
NPD6797 |
Phase 2 |
0.9222 |
High Similarity |
NPD7251 |
Discontinued |
0.9167 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9096 |
High Similarity |
NPD3818 |
Discontinued |
0.8976 |
High Similarity |
NPD6166 |
Phase 2 |
0.8976 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8976 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8957 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8827 |
High Similarity |
NPD1934 |
Approved |
0.8817 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8773 |
High Similarity |
NPD2801 |
Approved |
0.8659 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8512 |
High Similarity |
NPD5494 |
Approved |
0.8443 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8391 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8364 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8343 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8221 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8176 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8166 |
Intermediate Similarity |
NPD5402 |
Approved |
0.814 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8132 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8107 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8075 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8045 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8045 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8025 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8011 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7955 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7923 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.791 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7886 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7882 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7857 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7829 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7795 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7795 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7751 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7738 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7735 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7735 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7733 |
Intermediate Similarity |
NPD37 |
Approved |
0.773 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7708 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7708 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7701 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7701 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7663 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7641 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7627 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7616 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7593 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7577 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7577 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7565 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7539 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7539 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.753 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1607 |
Approved |
0.75 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7485 |
Intermediate Similarity |
NPD943 |
Approved |
0.7475 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD7874 |
Approved |
0.747 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7458 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7439 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7437 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7416 |
Intermediate Similarity |
NPD919 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7381 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7346 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7333 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7333 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.733 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.733 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.733 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7326 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7326 |
Intermediate Similarity |
NPD2534 |
Approved |
0.731 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7284 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7282 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7249 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7249 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD920 |
Approved |
0.7235 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7159 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7128 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7069 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7065 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7029 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7026 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7026 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7019 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7018 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7015 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.6973 |
Remote Similarity |
NPD5242 |
Approved |
0.697 |
Remote Similarity |
NPD9494 |
Approved |
0.6967 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD5353 |
Approved |
0.695 |
Remote Similarity |
NPD5006 |
Approved |
0.695 |
Remote Similarity |
NPD5005 |
Approved |
0.6948 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6948 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6946 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6936 |
Remote Similarity |
NPD1243 |
Approved |
0.6928 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD5710 |
Approved |
0.6919 |
Remote Similarity |
NPD5711 |
Approved |
0.6914 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD2798 |
Approved |
0.6905 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6865 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6857 |
Remote Similarity |
NPD2309 |
Approved |
0.6856 |
Remote Similarity |
NPD6841 |
Approved |
0.6856 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6856 |
Remote Similarity |
NPD6842 |
Approved |
0.6848 |
Remote Similarity |
NPD1203 |
Approved |
0.6845 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6842 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6836 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6834
|
Remote Similarity |
NPD4420 |
Approved |